Target (CBDY) EBT Growth (3y) (2016 - 2026)
Target (CBDY) EBT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 53.36% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.84% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 33.51% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 63.73% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -6.95% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -76.13% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -118.90% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 152.43% |
| 10 | Target | - | - | 191,787.00 | 9.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.63% |
| Dec 31, 2025 | -95.08% |
| Sep 30, 2025 | -18.77% |
| Jun 30, 2025 | -42.40% |
| Mar 31, 2025 | 42.18% |
| Dec 31, 2024 | 36.63% |
| Sep 30, 2024 | -30.86% |
| Jun 30, 2024 | -6.93% |
| Mar 31, 2024 | 58.44% |
| Dec 31, 2023 | 67.45% |
| Sep 30, 2023 | 55.00% |
| Jun 30, 2023 | 53.30% |
| Mar 31, 2023 | -31.34% |
| Dec 31, 2022 | 26.34% |
| Sep 30, 2022 | 34.09% |
| Jun 30, 2022 | 28.33% |
| Mar 31, 2022 | 21.11% |
| Dec 31, 2021 | -39.38% |
| Sep 30, 2021 | 47.36% |
| Jun 30, 2021 | 43.89% |